GlycoMimetics Inc (GLYC)
0.2716
0.00 (0.00%)
USD |
NASDAQ |
May 31, 16:00
0.2711
0.00 (0.00%)
After-Hours: 20:00
GlycoMimetics Accounts Payable (Quarterly): 0.7555M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 0.7555M |
December 31, 2023 | 0.8681M |
September 30, 2023 | 0.3299M |
June 30, 2023 | 0.2415M |
March 31, 2023 | 0.4802M |
December 31, 2022 | 0.9702M |
September 30, 2022 | 0.8521M |
June 30, 2022 | 1.271M |
March 31, 2022 | 2.276M |
December 31, 2021 | 2.108M |
September 30, 2021 | 1.390M |
June 30, 2021 | 1.175M |
March 31, 2021 | 2.141M |
December 31, 2020 | 2.090M |
September 30, 2020 | 1.074M |
June 30, 2020 | 1.371M |
March 31, 2020 | 3.134M |
December 31, 2019 | 1.436M |
September 30, 2019 | 1.408M |
June 30, 2019 | 3.027M |
March 31, 2019 | 1.867M |
December 31, 2018 | 2.664M |
September 30, 2018 | 0.6594M |
Date | Value |
---|---|
June 30, 2018 | 3.240M |
March 31, 2018 | 3.854M |
December 31, 2017 | 2.647M |
September 30, 2017 | 1.632M |
June 30, 2017 | 0.5751M |
March 31, 2017 | 0.5117M |
December 31, 2016 | 1.565M |
September 30, 2016 | 1.247M |
June 30, 2016 | 1.397M |
March 31, 2016 | 1.623M |
December 31, 2015 | 0.5642M |
September 30, 2015 | 0.6331M |
June 30, 2015 | 1.107M |
March 31, 2015 | 1.184M |
December 31, 2014 | 0.874M |
September 30, 2014 | 0.5837M |
June 30, 2014 | 0.4722M |
March 31, 2014 | 1.797M |
December 31, 2013 | 1.145M |
September 30, 2013 | 1.754M |
June 30, 2013 | 0.5388M |
December 31, 2012 | 0.7642M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.2415M
Minimum
Jun 2023
3.134M
Maximum
Mar 2020
1.420M
Average
1.321M
Median
Accounts Payable (Quarterly) Benchmarks
Altimmune Inc | 3.76M |
Lyell Immunopharma Inc | 4.895M |
Amicus Therapeutics Inc | 9.21M |
InfuSystems Holdings Inc | 9.796M |
Nanoviricides Inc | 0.5545M |